Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|May 26, 2017
A human monocytic NF-κB fluorescent reporter cell line for detection of microbial contaminants in biological samplesClaire Battin, Annika Hennig, Patrick Mayrhofer, et al.
Biotechnology and Bioengineering|February 26, 2016
Proteomic differences in recombinant CHO cells producing two similar antibody fragmentsWolfgang Sommeregger, Patrick Mayrhofer, Willibald Steinfellner, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2021
Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgGLin Sun, Somanath Kallolimath, Roman Palt, et al.
Frontiers in Bioengineering and Biotechnology|March 3, 2020
Getting CD19 Into Shape: Expression of Natively Folded "Difficult-to- Express" CD19 for Staining and Stimulation of CAR-T CellsElisabeth Lobner, Anna Wachernig, Venugopal Gudipati, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2021
Highly active engineered IgG3 antibodies against SARS-CoV-2Somanath Kallolimath, Lin Sun, Roman Palt, et al.
Applied Microbiology and Biotechnology|August 28, 2014
Accurate comparison of antibody expression levels by reproducible transgene targeting in engineered recombination-competent CHO cellsPatrick Mayrhofer, Bernhard Kratzer, Wolfgang Sommeregger, et al.
Biotechnology Journal|April 28, 2018
Bioprocessing of Recombinant CHO-K1, CHO-DG44, and CHO-S: CHO Expression Hosts Favor Either mAb Production or Biomass SynthesisDavid Reinhart, Lukas Damjanovic, Christian Kaisermayer, et al.
Frontiers in Medicine|March 4, 2022
SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 YearErika Garner-Spitzer, Angelika Wagner, Michael Kundi, et al.
Ebiomedicine|September 6, 2023
Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formationErika Garner-Spitzer, Angelika Wagner, Venugopal Gudipati, et al.
Pageof 2